A recent study by Bodac et al.[41] reported that tumor cell‐derived GM‐CSF triggered the expression of the anti‐apoptotic Bcl‐xL protein and enhanced neutrophil survival in a genetically engineered mouse model of lung adenocarcinoma, which differed slightly from our human cell‐based study. The gene discussed is BCL2L1; the disease is neoplasm.